Peptide introduction： ACE Inhibitors/Teprotide/Angiotensin converting enzyme inhibitor
| English name | Teprotide/Angiotensin converting enzyme inhibitor/BPP 9A |
| CAS NO | 35115-60-7 |
| Synonym | teprotide ;
PGLU-TRP-PRO-ARG-PRO-GLN-ILE-PRO-PRO; PYR-WPRPQIPP; PYROGLU-TRP-PRO-ARG-PRO-GLN-ILE-PRO-PRO; PYR-TRP-PRO-ARG-PRO-GLN-ILE-PRO-PRO; PYR-TRP-PRO-ARG-PRO-GLN-ILE-PRO-PRO-OH;SQ 20881; Angiotensin-converting enzyme inhibitor, ≥95% (TLC) |
| Peptide sequence | Glp-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro |
| Molecular formula | C53H76N14O12 |
| Molecular weight | 1101.3 |
| storage temperature | 2-8℃ |
| purity | ≥95%or 98% |
| Packing specification | 1mg;5mg;10mg;50mg;100mg,1g or according to customer’s detail requirement. |
Teprotide properties usage and production technology
BPP 9A effect
Teprotide is an angiotensin-converting enzyme inhibitor. Converting enzyme inhibitors mainly act by inhibiting the conversion of angiotensin I to angiotensin II. Thus, the vasoconstrictive effect of angiotensin II is essentially minimized.
BPP 9A Application
The pharmaceutical preparations for preventing stroke, diabetes, and/or bloody heart failure due to Chemicalbook use angiotensin-converting enzyme (ACE) inhibitors including teprotide and angiotensin II type 1 receptor (ATII) antagonists. ACE inhibitors are compounds that can inhibit the conversion of angiotensin I into active angiotensin II and the decomposition of active bradykinin.
Remetide Biotech, LLC is a professional manufacturer of custom peptide synthesis. We provide professional BPP 9A R&D and sales services.